ARCA biopharma sets Jan 30, 2024 annual meeting, Dec 6 record date, Dec 11 proposal deadline

Oruka Therapeutics, Inc.

Annual meeting scheduled for January 30, 2024; record date for voting is December 6, 2023.
Shareholder proposals or director nominations must be received by December 11, 2023.
Proxy materials expected to be available beginning on or about December 19, 2023.

item 5.08 item 9.01

Oruka Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-068189

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.